GILEAD SCIENCES, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Gilead Sciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Gilead Sciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$297M, a 303% decline year-over-year.
  • Gilead Sciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $62M, a 95.6% decline year-over-year.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.25B, a 0.08% decline from 2022.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.25B, a 39.9% decline from 2021.
  • Gilead Sciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.08B, a 31.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.25B -$1M -0.08% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $1.25B -$829M -39.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $2.08B +$497M +31.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 $1.58B +$1.78B Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$204M -$2.54B -109% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $2.34B -$6.55B -73.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $8.89B +$5.28B +146% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $3.61B +$56M +1.58% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $3.55B +$756M +27% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $2.8B +$1.65B +143% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $1.15B +$113M +10.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-24
2012 $1.04B +$176M +20.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $862M -$162M -15.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $1.02B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.